Literature DB >> 11792339

Comparison of modifiable determinants of lipids and lipoprotein levels among African-Americans, Hispanics, and Non-Hispanic Caucasians > or =65 years of age living in New York City.

Carlos Rodriguez1, Ariel Pablos-Méndez, Walter Palmas, Rafael Lantigua, Richard Mayeux, Lars Berglund.   

Abstract

Information on determinants of plasma lipids and lipoproteins and how these factors would differ among race/ethnic groups in elderly populations is scarce. We studied cross-sectionally the distribution and predictors of lipids and lipoproteins in 1,118 free-living elderly subjects (> or =65 years of age), in a multiethnic urban community (22% non-Hispanic Caucasian, 34% African-American, and 44% Hispanic). Mean levels of total cholesterol, total/high-density lipoprotein (HDL) cholesterol ratio, and triglycerides decreased with increasing age (p <0.001). Low-density lipoprotein cholesterol and total cholesterol were lower among men, whereas women had higher levels of HDL cholesterol (p <0.001). Hispanics had lower low-density lipoprotein cholesterol, total cholesterol, and HDL cholesterol levels, whereas African-Americans had a lower total/HDL cholesterol ratio and triglyceride levels along with higher HDL cholesterol levels (p <0.001). Diabetes was more prevalent among Hispanics and African-Americans (p = 0.002), and body mass index was higher in African-Americans (p = 0.009). Hispanics were less likely to drink alcohol (p <0.0001), but more likely to drink larger amounts of coffee (p <0.0001). A greater proportion of African-Americans were active smokers (p <0.001). In multivariate regression models, body mass index was a significant independent predictor of total cholesterol (beta = 0.74, p <0.001). Waist circumference predicted lower HDL cholesterol levels (0.57 mg/dl lower per inch, p <0.001) and a higher total/HDL cholesterol ratio (beta = 0.05, p <0.001). Alcohol intake (>2 g/day) predicted higher HDL cholesterol (beta = 6.20, p <0.001). Diabetic status predicted lower HDL cholesterol (beta = -2.47, p <0.05), higher total/HDL cholesterol ratio (beta = 0.35, p <0.001), and triglycerides (beta = 37.10, p <0.001). Physical activity, coffee intake, and a calorie-adjusted atherogenicity index did not show independent predictive value. These findings indicate that obesity, alcohol intake, and diabetes mellitus are potentially modifiable independent determinants of lipids and lipoprotein levels in an elderly multiethnic population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792339     DOI: 10.1016/s0002-9149(01)02197-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  19 in total

Review 1.  Managing cardiovascular risk in minority patients.

Authors:  Keith C Ferdinand
Journal:  J Natl Med Assoc       Date:  2005-04       Impact factor: 1.798

2.  Genetic architecture of lipid traits changes over time and differs by race: Princeton Lipid Follow-up Study.

Authors:  Jessica G Woo; John A Morrison; Davis M Stroop; Lisa Aronson Friedman; Lisa J Martin
Journal:  J Lipid Res       Date:  2014-05-25       Impact factor: 5.922

3.  Metabolic syndrome as an underlying disease entity and its relationship to subclinical atherosclerosis in Andean Hispanics.

Authors:  Diana A Chirinos; Josefina Medina-Lezama; William Arguelles; Ronald Goldberg; Neil Schneiderman; Zubair Khan; Oscar O Morey; Muhammad Waheed Raja; Roberto Paz; Julio A Chirinos; Maria M Llabre
Journal:  Metab Syndr Relat Disord       Date:  2013-11-08       Impact factor: 1.894

4.  Do all components of the metabolic syndrome cluster together in U.S. Hispanics/Latinos? Results from the Hispanic Community Health study/Study of Latinos.

Authors:  Maria M Llabre; William Arguelles; Neil Schneiderman; Linda C Gallo; Martha L Daviglus; Earle C Chambers; Daniela Sotres-Alvarez; Diana A Chirinos; Gregory A Talavera; Sheila F Castaneda; Scott C Roesch; Gerardo Heiss
Journal:  Ann Epidemiol       Date:  2015-02-19       Impact factor: 3.797

5.  Changes in glycemic control are associated with changes in cognition in non-diabetic elderly.

Authors:  Ramit Ravona-Springer; Erin Moshier; James Schmeidler; James Godbold; Jimmy Akrivos; Michael Rapp; Hillel T Grossman; Michael Wysocki; Jeremy M Silverman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  Race-ethnic differences in the association between lipid profile components and risk of myocardial infarction: The Northern Manhattan Study.

Authors:  Joshua Z Willey; Carlos J Rodriguez; Richard F Carlino; Yeseon Park Moon; Myunghee C Paik; Bernadette Boden-Albala; Ralph L Sacco; Marco R DiTullio; Shunichi Homma; Mitchell S V Elkind
Journal:  Am Heart J       Date:  2011-05       Impact factor: 4.749

7.  Ethnic differences in aortic valve thickness and related clinical factors.

Authors:  Yukiko Sashida; Carlos J Rodriguez; Bernadette Boden-Albala; Zhezhen Jin; Mitchell S V Elkind; Rui Liu; Tatjana Rundek; Ralph L Sacco; Marco R DiTullio; Shunichi Homma
Journal:  Am Heart J       Date:  2010-04       Impact factor: 4.749

8.  Genome-wide linkage analysis replicates susceptibility locus for fasting plasma triglycerides: NHLBI Family Heart Study.

Authors:  Donna K Arnett; Michael B Miller; Hilary Coon; R Curtis Ellison; Kari E North; Michael Province; Mark Leppert; John H Eckfeldt
Journal:  Hum Genet       Date:  2004-09-16       Impact factor: 4.132

9.  Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.

Authors:  Lukas Kubala; Guijing Lu; Stephan Baldus; Lars Berglund; Jason P Eiserich
Journal:  Clin Chim Acta       Date:  2008-04-08       Impact factor: 3.786

10.  Dyslipidemia patterns among Hispanics/Latinos of diverse background in the United States.

Authors:  Carlos J Rodriguez; Martha L Daviglus; Katrina Swett; Hector M González; Linda C Gallo; Sylvia Wassertheil-Smoller; Aida L Giachello; Yanping Teng; Neil Schneiderman; Gregory A Talavera; Robert C Kaplan
Journal:  Am J Med       Date:  2014-09-03       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.